Contact Info
Education
2001 B.S. in Biochemistry, Chung-Ang University, Korea
2003 M.S. in Biochemistry, Chung-Ang University, Korea
2008 Ph.D. in Biochemistry, The University of Georgia, USA
Experience
2017 - present Assistant Professor, Chung-Ang University, Korea
2013 - 2016 Post-doctoral fellow, Baylor College of Medicine, USA
Research Interests

• Development of Diabetes drug

• Diabetes metabolism

• Skeletal muscle fuel metabolism

• Diabetes clinical research

Selected Publications

1. Hong, S., Ding, G., Zhou W, Cao, R., and Sun Z. Enhanced Muscle insulin sensitivity

after Exercise is controlled by Ampd3 and HDAC3 complex, Manuscript in preparation

2. Noh, H., Yan, J., Hong, S., Kong LY., Gabrusiewicz K., Xia, X., Heimberger, A., and Li. S. Cell surface vimentin targeted mAb 86C increases sensitivity to temozolomide mediated cell death in glioma stem cells, Manuscript in preparation

3. Hong, S., Zhou W, He, Y., Ding, G., York, B., Wang, C., Xu, Y., and Sun Z. NCOR/HDAC3 Mediates Circadian Disruption-Induced Cognitive Deficit Through Modulating GABA Signaling, Submitted to Nature Neuroscience SCI IF=16.727

4. Gong, Y., Cao, R., Ding, G., Hong, S., Zhou W, and Sun, Z. Integrated omics approach in addressing the function of nuclear receptor corepressor complex in skeletal muscle, Submitted to Molecular and Cellular Endocrinology SCI IF=4.405

5. Hong, S., Zhou W, Fang B, Lu W, Loro E, Damle M, Ding G, Jager J, Zhang S, Zhang Y, Feng D, Chu Q, Dill BD, Molina H, Khurana TS, Rabinowitz JD, Lazar MA, Sun Z.(2016), Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3. Nature Medicine, in press SCI IF=30.357

6. Noh H, Yan J, Hong, S., Kong LY, Gabrusiewicz K, Xia X, Heimberger AB, Li S.(2016), Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells. Oncotarget, doi: 10.18632/oncotarget.12458 SCI IF=6.359

7. Hong, S., Noh, H., Teng, Y., Shao, J., Rehmani, H., Ding, HF., Dong, Z., Su, SB., Shi H., Kim, J., and Huang, S.(2014), SHOX2 is a direct miR-375 target and a novel epithelial-tomesenchymal transition inducer in breast cancer cells, Neoplasia, Selected as a Cover Page, 16(4): 279- 290. SCI IF=5.946

8. Shao, J., Teng, Y., Padia, R., Hong, S., Noh, H., Xie, X., Mumm, J., Dong, Z., Ding, H-F., Cowell, J., Kim, J., Han, J., and Huang, S.(2013), COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell metastasis, Neoplasia, 15(9): 1075-1085. SCI IF=5.946

9. Hong, S.*, Noh, H.*, Chen, H., Padia, R., Pan, Z., Su, S-B., Jing, H-F., and Huang,

S. (2013), Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs, Science Signaling, 6(266), ra16. SCI IF=7.4

10. Noh, H., Hong, S., and Huang, S. (2013), Role of urokinase receptor in tumor progression and development, Theranostics, 25;3(7):487-495. SCI SCI IF=8.854

11. Hu, Q., Lu, Y-Y., Noh, H., Hong, S., Dong, Z., Ding, H-F., and Huang, S. (2012), Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression, Oncogene, 1-11. SCI IF=8.459

12. Noh, H., Hong, S., Dong, Z., Pan, Z., Jing, Q., and Huang, S. (2011), Impaired microRNA processing facilitates breast cancer cell invasion by upregulating urokinase-type plasminogen activator expression, Genes & Caners, 2(2), 140-150. SCI IF=5.39